quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:30:40·721d
SECFiling
Tristar Acquisition I Corp. logo

Tristar Acquisition I Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

TRIS· Tristar Acquisition I Corp.
Finance
Original source

Companies

  • TRIS
    Tristar Acquisition I Corp.
    Finance

Related

  • PR538d
    Helport AI Reports Fiscal Full Year 2024 Financial Results
  • SEC619d
    SEC Form 15-12G filed by Tristar Acquisition I Corp.
  • SEC622d
    Tristar Acquisition I Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
  • SEC623d
    Tristar Acquisition I Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
  • SEC629d
    Amendment: Tristar Acquisition I Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
  • SEC629d
    Tristar Acquisition I Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
  • SEC629d
    SEC Form 25-NSE filed by Tristar Acquisition I Corp.
  • PR629d
    Helport AI Limited and Tristar Acquisition I Corp. Announce Closing of Business Combination and listing on Nasdaq
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022